Medical Properties Trust: $413 Million for Two Hospitals — and the Lenders Stand First in Line

The pay-versus-performance table in Medical Properties Trust’s 2026 proxy statement (DEF 14A) lists the stock price at $23.63 for 2021, $11.14 for 2022, $4.91 for 2023, $3.95 for 2024 and $5.00 for 2025. On October 9, 2026, the stock closed at $3.14. Anyone who bought at the end of 2021 and added at every year-end since always had a reason: the price is already so low, the dividend so high, and every purchase pulls your own average price down.

Investors call this averaging down. It feels like progress, because the number in your brokerage account, your cost basis, keeps falling. The trap: your own purchase price becomes the yardstick for whether a stock is “cheap.” The company does not care about that price. What the stock is really worth depends on rents, debt and interest, not on the memory of $23. The same table puts total shareholder return at the end of 2025 at 37.95, measured against 100 at the start of the table period in 2021, with dividends reinvested. A health care real estate index came in at 163.81 over the same period.

So let’s make a deal: we forget the old prices and read together what Medical Properties Trust itself reports to the U.S. securities regulator, the SEC. The tension at the heart of this analysis: At least some of MPT’s hospitals are worth more than they carry on the books — for two hospitals in Idaho, a buyer paid well above the original investment in 2026. But MPT plans to use most of the money from those sales to pay down debt, and its most recent major refinancing had to be secured by real estate and carries 9.25 percent interest.

What Medical Properties Trust actually does

Medical Properties Trust, or MPT, does not run hospitals. It owns the buildings and leases them to hospital operators on long contracts; according to the 2025 annual report, the weighted average remaining initial term of its leases and loans was 16.7 years. Think of a landlord that rents out entire hospitals instead of apartments. Tenants pay operating costs, taxes, insurance and maintenance themselves (a “net lease”). MPT collects the rent, which rises every year under leases representing 99 percent of current monthly revenue (as of year-end 2025). Rent makes up about 95 percent of revenue.

As of June 30, 2026, MPT owned 373 properties with roughly 38,000 beds, leased to or mortgaged by 51 operators in nine countries: the United States, the United Kingdom, Switzerland, Germany, Spain, Finland, Colombia, Italy and Portugal. Half of its assets sit in the U.S., 27.6 percent in the U.K. The largest tenant is British hospital group Circle Health, with 21.1 percent of second-quarter 2026 revenue, followed by British mental health group Priory at 10.6 percent. All of this is managed by 121 employees (as of February 2026). MPT was founded in 2003 in Birmingham, Alabama. Founder Edward K. Aldag Jr. leads it today as chairman, president and CEO; he has been a director since 2004.

MPT is a REIT (real estate investment trust), a property company with a tax privilege: it pays no U.S. corporate income tax on the income it distributes (foreign taxes and taxes at taxable subsidiaries still apply; $38.6 million in 2025), but must distribute at least 90 percent of its taxable income. That is why many investors buy REITs for the dividend. Since February 2026, the stock has traded on the New York Stock Exchange under the symbol MPT instead of MPW; the company is the same.

How the stock landed on our desk

MPT made our research list through the forum ranking of wallstreet-online, the list of stocks most discussed by German retail investors (as of October 11, 2026). That is a signal of attention, not of quality. But our in-house stock scanner knows MPT too: the stock appears in the price-to-cash-flow ranking, which collects stocks trading at no more than 10 times operating cash flow (as of October 11, 2026). By our calculation, MPT’s market value came to about 8 times the operating cash flow of the last four quarters ($1.875 billion against $227 million). One caveat: that cash flow is already counted after interest payments, so interest does not eat into it a second time. But it still has to cover the dividend.

And there is another number showing that retail investors are not the only ones watching: about 146 million MPT shares were sold short (source: fundamental data, retrieved October 11, 2026), about 30 to 33 percent of the freely tradable shares: the fundamental data show 32.8 percent; using the float stated there, our own calculation gives 29.8 percent. Short sellers profit when the price falls. A share that high means a lot of money is betting against MPT. That can reverse if the news improves, but for now it is a clear vote of no confidence. For a hospital landlord with a smaller balance sheet and a different tenant base, see our analysis of Community Healthcare Trust.

The numbers over the years

First, what impresses. The second quarter of 2026 shows a recovery: rent billed rose 14 percent year over year to $203.4 million, revenue 8 percent to $259.3 million. Normalized FFO, the measure REITs use for their ongoing earnings from operations (net income plus depreciation, excluding one-off items; it still includes straight-line rent not yet received in cash), rose to $0.15 per share from $0.14 a year earlier. According to the quarterly report, the biggest contribution to higher lease revenue came from the re-tenanted former Steward and Prospect hospitals, up $16.4 million year over year.

And the buildings themselves are in demand. On September 16, 2026, MPT sold two hospitals in Idaho to Intermountain Health for $413 million; MPT received $371 million in cash, with $42 million going to minority owners. According to MPT, the gross investment in the two properties was about $240 million; MPT puts the gain over gross book value at about $130 million. Together with the IPO of its Swiss hospital real estate holding Infracore in July and the sale of its interest in five Utah hospitals in August, MPT reports roughly $680 million of sale proceeds for the third quarter of 2026. Most of it is meant to pay down debt.

Now the sobering part, and it is in the chart.

In 2022, MPT still paid $0.29 per share per quarter. In August 2023, it nearly halved the dividend to $0.15, and in August 2024 cut it again to $0.08. Since the increase declared in November 2025 (first paid in January 2026), it has been $0.09 per quarter. The cuts came while two major tenants were sliding into trouble. For Steward Health Care, once one of the largest tenants, MPT already recorded $714 million of impairments and reserves in 2023; Steward filed for bankruptcy in May 2024, and in 2024 alone it cost MPT $1.56 billion in impairments. In January 2025, Prospect Medical Holdings, another major tenant, filed for bankruptcy as well. Net income attributable to shareholders swung from $902.6 million in 2022 to losses of $556.5 million (2023), $2.41 billion (2024) and $277.0 million (2025). The first half of 2026 brought a small profit of $30.2 million, mostly thanks to a $22.7 million income tax benefit, driven largely by a one-time deferred tax adjustment in the U.K.

Ongoing operating earnings have shrunk too: normalized FFO per share fell from $1.59 (2023) to $0.80 (2024) and $0.58 (2025). Revenue was $972.0 million in 2025, down from $1.54 billion in 2021. Remember: the 2026 recovery is real, but it starts from a level that is only a fraction of what it used to be.

Uncomfortable truth no. 1: Money is getting more expensive

A landlord that buys buildings on credit earns the spread between rental yield and interest. At MPT, that spread has become thin. As of June 30, 2026, the company had $9.83 billion of debt at a weighted average interest rate of 5.37 percent. Interest expense was $510.4 million in 2025, or 52.5 percent of revenue. In 2021 it was 23.8 percent. More than every second dollar of revenue now goes to lenders before overhead, depreciation or shareholders get their turn.

The 2023 revenue figure is depressed: it includes the straight-line rent line at minus $127.9 million, because MPT wrote off such receivables, mainly at Steward. That does not change the picture. Most of MPT’s debt comes due in a single payment at maturity and then has to be refinanced. The annual report is candid about what that means:

“There is a risk that we may not be able to extend, refinance, or pay off debt maturing in 2026 and future years or that the terms of any refinancing will not be as favorable as the terms of the then-existing debt.”

— Medical Properties Trust, SEC annual report 10-K for 2025, Item 1A Risk Factors (Financing Risks)

That is exactly what happened on August 10, 2026. MPT issued $2.4 billion of new notes due 2032, at 9.25 percent interest and secured by real estate. About $1.0 billion came in as cash, earmarked to retire the 2026 euro notes (0.993 percent) in full and about 27 percent of the 2027 notes (5.0 percent). The rest was an exchange in which holders swapped older unsecured notes maturing between 2027 and 2031, with coupons between 3.375 and 5.0 percent. MPT expects to capture a discount of about $123 million, net of certain lender fees. But the new notes alone cost $222 million in interest a year ($2.4 billion times 9.25 percent). MPT does not quantify how much the overall interest burden rises; only the direction is clear: the retired notes carried coupons between 0.993 and 5.0 percent, the new ones carry 9.25 percent.

Back in February 2025, MPT had already issued $1.5 billion of secured notes at 8.5 percent and €1.0 billion at 7.0 percent. According to the contractual commitments table in the quarterly report, the secured notes alone will require $430.2 million in each year from 2027 through 2030. And “secured” means: specific properties stand behind these lenders first. If you want to understand the pecking order in a crisis: secured lenders at the front, unsecured lenders next, shareholders at the very back.

Add a deadline: MPT’s credit facility matures on December 30, 2026, with an option to extend six months to June 30, 2027, subject to certain conditions. As of August 10, 2026, $475.3 million was drawn. According to the quarterly report, MPT was in compliance with all covenants as of August 10, 2026, and lists a new multi-year credit facility as one option. MPT’s adjusted net debt (excluding about $559 million spent on development and capital addition projects) stood at 8.9 times adjusted EBITDAre (earnings before interest, taxes, depreciation and amortization for real estate, annualized from the second quarter of 2026); without that adjustment it would be about 9.5 times by our calculation.

Uncomfortable truth no. 2: Part of the rent is not cash yet

MPT’s leases include annual rent increases. Accounting rules require the rent to be smoothed over the full lease term (“straight-line rent”). That means part of the increases that will only be paid many years from now already shows up as revenue today. Picture a tenant who pays $1,000 today and $1,500 in 20 years. The books record an average in between from day one. The difference is a receivable, not money in the bank.

At MPT, that is a big number. In the second quarter of 2026, $33.3 million of $259.3 million in revenue was straight-line rent, about 13 percent; in 2025 it was almost 16 percent (our calculations). On the balance sheet, these future rents have grown to $927.5 million, 20.6 percent of equity (June 30, 2026). They only turn into cash if the tenant lasts to the end of the lease. If it fails, the receivable is written off. That has already happened at MPT: in 2023, among other things, it set up a $413 million reserve for Steward rent arrears and straight-line rent.

There is a second effect: several tenants pay so unreliably that MPT only books their rent as revenue once the cash arrives. The quarterly report puts it this way:

“We currently have several tenants on the cash basis from a revenue recognition perspective, which can result in variability of our lease revenue quarter-to-quarter.”

— Medical Properties Trust, SEC quarterly report 10-Q for June 30, 2026, Item 2 (Results of Operations)

One of these tenants is NOR Healthcare Systems, to which MPT re-leased six former Prospect hospitals in California in December 2025. All rent there was deferred for the first six months, and half of it is deferred for another six; in the second quarter of 2026, MPT booked just $1 million of revenue from NOR. And at Prospect itself, MPT’s remaining investment was about $67 million as of June 30, 2026, including a $3 million commitment MPT still expected to fund in the third quarter of 2026. MPT believes the amount is fully recoverable, from remaining Connecticut receivables and from litigation and other causes of action, but says their ultimate outcome and timing are uncertain.

Uncomfortable truth no. 3: The new tenants need loans

The good news above has a flip side. The six operators that took over 18 of the former Steward hospitals in September 2024 are indeed paying much more: about $3.4 million in the first quarter of 2025, already $29.7 million in the second quarter of 2026. From October 2026 they are scheduled to pay about 100 percent of contractual rent. The catch: MPT is also financing these tenants. As of June 30, 2026, it had lent them about $172 million in working capital and other loans. And for the largest of them, Healthcare Systems of America (HSA), MPT had to add more in the second quarter of 2026:

“In the 2026 second quarter, we advanced an additional $50 million to HSA due to ongoing revenue cycle management issues, of which we have subsequently received approximately $25 million.”

— Medical Properties Trust, SEC quarterly report 10-Q for June 30, 2026, Note 3 (Other Re-tenanting Activity)

Why this matters: with 8.5 percent of assets, HSA is MPT’s third-largest tenant. MPT publishes no rent coverage for HSA, meaning no figure for how many times the operator could pay its rent out of its own earnings. The same is true for 14 operators with a combined investment of about $2.96 billion, NOR among them; in part the figure is simply not required, and the 14 also include investment-grade tenants and Britain’s state-run NHS. And for two of the smaller transition tenants, Insight and Tenor, MPT already recorded $27.4 million of loan impairments in the first half of 2026. A landlord that lends working capital to its tenant carries that tenant’s risk twice: as landlord and as lender. Whether rent flows on its own will only show in the quarters after October 2026.

Then there is the concentration in the U.K.: Circle Health alone brings in a little over a fifth of revenue, Priory another tenth. MPT itself writes that it has no operational control over its tenants’ business. If a large tenant with cross-defaulted leases fails, the annual report says, the hit to MPT would be even more pronounced.

Uncomfortable truth no. 4: The dividend is on the list

In the first half of 2026, operations generated just $48.2 million of cash, after interest payments of $279.5 million (a year earlier: $220.3 million). In the first quarter, operating cash flow was actually negative, at minus $14.3 million. In the same half-year, MPT paid out $109.6 million in dividends, more than twice as much. Cash on hand, the credit facility and property sales close the gap. In its quarterly report, MPT lists where money for upcoming maturities could come from, and one item on that list is the dividend:

“reducing our dividend (or switching to a stock dividend), while still complying with REIT requirements and credit facility covenants;”

— Medical Properties Trust, SEC quarterly report 10-Q for June 30, 2026, Item 2 (Long-term Liquidity Requirements)

To be fair: this is a list of options, not an announcement. The same list includes property sales, a new credit facility and monetizing investments in operators, and with roughly $680 million from the third quarter, MPT has delivered on sales. On August 13, 2026, MPT again declared $0.09 per share, payable on October 8, 2026. Measured against normalized FFO of $0.29 in the first half, the $0.18 dividend is covered. Measured against the cash that actually came out of the business after interest, it was not covered in the first half. This is where a metric and a bank balance part ways.

What the stock costs

At the closing price of $3.14 on October 9, 2026, and 597.2 million shares, MPT was worth about $1.88 billion. Add debt minus cash (as of June 30, 2026) and the whole company costs about $11.3 billion. That shows the proportions: about 83 percent of enterprise value is debt net of cash, about 17 percent is shareholders’ equity. A 10 percent rise in property values would benefit shareholders disproportionately, but a 10 percent drop would hit them disproportionately too. That is the leverage built into every heavily indebted stock.

At first glance the stock looks cheap: equity stood at $7.54 per share on June 30, 2026, so the market valued it at less than half of book value (about 0.42). Based on second-quarter normalized FFO annualized ($0.60 a year), you pay about 5 times. The $0.36 annual dividend equals a yield of about 11.5 percent at the October 9, 2026, price (all our calculations). These are exactly the numbers that invite averaging down. That the market prices them this low is unlikely to be an accident: after billions in write-downs, investors apparently distrust book values and price in the interest burden of the coming years.

The view from the pros: of eight analysts covering the stock, three rated it a buy, three a hold and two a sell; the average price target was $5.13 (as of October 11, 2026, source: fundamental data). A price target is an opinion, not a promise; for MPT it hinges mainly on whether the new tenants really pay in full from October 2026.

Upside and risks at a glance

What speaks for MPT:

• The buildings have market value: two Idaho hospitals sold for $413 million ($371 million of it in cash to MPT) against roughly $240 million of gross investment (September 16, 2026); about $680 million of sale proceeds in the third quarter of 2026.
• Rental income is rising again: rent billed up 14 percent to $203.4 million in the second quarter of 2026; Steward’s successors paid $29.7 million in the quarter and are scheduled to pay about full contractual rent from October 2026.
• Long leases: 85.8 percent of annual base rent and interest expires only after 2035 (June 30, 2026), and leases representing 99 percent of monthly revenue include annual escalators (year-end 2025).
• The next big maturities are defused: after the August 10, 2026, refinancing, only the credit facility ($475.3 million) comes due in 2026 and about $865 million in 2027.

What speaks against MPT:

• High and increasingly expensive debt: $9.83 billion as of June 30, 2026 (about $9.51 billion as of August 10, 2026, after the refinancing and a partial paydown of the credit facility), adjusted net debt at 8.9 times adjusted EBITDAre (company figure); new notes at 9.25 percent, secured by real estate.
• Interest eats more than half of revenue (52.5 percent in 2025); in the first half of 2026, operating cash flow of $48.2 million fell short of $109.6 million in dividends paid.
• Uncertain tenants: several tenants on the cash basis, a $50 million additional advance to HSA, no published rent coverage for HSA and NOR, concentration risk in Circle Health (21.1 percent of revenue).
• $927.5 million of straight-line future rent on the balance sheet that only turns into cash if tenants honor their leases.
• The credit facility matures on December 30, 2026 (option to June 30, 2027, subject to conditions); MPT itself lists a dividend cut as a possible source of cash.

A human conclusion

Remember averaging down? With MPT, anyone who bought at the end of 2021 and added at every year-end through 2025 would have lowered the average price each time, and every one of those purchases would be under water at the October 9, 2026, price. That is not only about the buildings. The Idaho sale shows that at least some of them hold their value: the buyer paid $413 million for two hospitals, $371 million of which went to MPT; the gross investment was about $240 million. It is because of who gets paid first if things go wrong. Between the buildings and the shareholders sat $9.8 billion of debt as of June 30, 2026, about $9.5 billion as of August 10, 2026; a growing share of it is secured, and the notes issued in 2025 and 2026 pay 7 to 9.25 percent. Whoever averages down is not buying the buildings, but what is left after the lenders. With about 30 to 33 percent of the freely tradable shares sold short, the stakes run both ways: if the next reports confirm the turnaround, many short sellers could buy back; if they do not, the short sellers will have been right.

The next test has a month attached: from October 2026, the new operators of the former Steward hospitals are supposed to pay about full contractual rent. In the quarterly report for September 30, 2026, and above all in the annual report for 2026, three lines are worth a look: cash rent from the transition tenants (most recently $29.7 million a quarter), the loan balance at HSA, and operating cash flow against the dividend. Only when these three numbers fit together will the dividend be earned by the business itself. Until then, a lower price is information, not a discount. What you make of it is your decision. And that is how it should be.

Sources

• Medical Properties Trust — quarterly report 10-Q for June 30, 2026 (filed August 10, 2026, latest periodic report) and 10-Q for March 31, 2026 (May 8, 2026)
• Annual report 10-K for 2025 (filed February 26, 2026) and 10-K for 2024 (March 3, 2025)
• Current reports 8-K of August 10, 2026: second-quarter 2026 earnings release, quarterly supplemental Q2 2026, new 9.25 percent notes due 2032; 8-K of January 20, 2026 (ticker change from MPW to MPT)
• Proxy statement DEF 14A 2026 (April 13, 2026; total shareholder return and stock prices 2021 to 2025)
• Medical Properties Trust press releases: dividend of August 13, 2026, sale of two hospitals of September 16, 2026
• Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) (closing price October 9, 2026; short interest, analyst ratings and price target as of October 11, 2026)

This analysis is a journalistic assessment based on publicly available company filings. It is not investment advice and not a solicitation to buy or sell securities. Stocks can lose value, up to a total loss. All figures carry the date of their source; prices are dated snapshots. Positions held by the operator are disclosed daily; where one exists, it appears as a notice at the top of this analysis.